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CASE REPORT Open Access
A novel mutation in ITGB4 gene in a
newborn with epidermolysis bullosa,
pyloric atresia, and aplasia cutis congenita
Emel Okulu1*, Ceren D. Durmaz2, Gaffari Tunc1, Adil Guzel3, Nuket Y. Kutlay2, Omer Erdeve1, Begum Atasay1,
John A. McGrath4, Lu Liu5 and Saadet Arsan1
Abstract
Background: Epidermolysis bullosa with pyloric atresia (EB-PA), also known as Carmi syndrome, is an uncommon,
autosomal recessive genodermatosis that typically affects the skin and gastrointestinal tract. EB-PA is caused by
homozygous or compound heterozygous mutations in the integrin alpha 6 (ITGA6) gene on chromosome 2q31.1 or
in the integrin beta 4 (ITGB4) gene on 17q25.1.
Case presentation: A male premature infant was born with aplasia cutis, atresia of the pylorus, and bilateral
hydronephrosis. His clinical and imaging findings were compatible with EB-PA. A novel, small deletion of the last
two bases in exon 6 and the first two nucleotides of intron 6 (c.565_566+2del) in ITGB4 gene was identified.
Conclusion: EB-PA-aplasia cutis congenita is known to be a non-treatable condition with a poor prognosis as the
reported case. The novel mutation reported in this patient may lead to the lethal form of this disease. Identification
of underlying genetic abnormality is critical to give genetic counseling.
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Background
Epidermolysis bullosa (EB) is a clinically and genetically
heterogeneous group of inherited skin diseases charac-
terized by blisters followed by skin and mucosal ero-
sions. EB has subgroups based on the ultrastructural
level. There are four subgroups: EB simplex, junctional
epidermolysis bullosa (JEB), dystrophic EB, and Kindler
syndrome [1–3].
JEB with pyloric atresia (JEB-PA, OMIM: 226730) is a
rare form of EB with multisystem involvement. Cutane-
ous manifestations, congenital pyloric atresia, and ur-
eteral and renal anomalies such as renal collecting
system defects, multicystic/dysplastic kidney, hydrone-
phrosis, and absent bladder are the characteristic
features of the disorder [4]. Cutaneous manifestations of
JEB-PA include severe mucocutaneus blisters, extreme
skin fragility, atrophic scarring, and milia (small white
spots). JEB-PA is caused by mutations in the ITGA6 or
ITGB4 genes coding for subunit alpha 6 (α6) or beta 4
(β4) of integrin [5, 6]. Additional features shared by JEB-
PA include aplasia cutis congenita (ACC) that means
congenital localized absence of the skin affecting the ex-
tremities, head, nail dystrophy, scarring alopecia, enamel
hypoplasia, contractures, and dilated cardiomyopathy
[7–9].
ITGA6, mapped to 2q31.1, is one of the genes known
to cause this phenotype. ITGA6 consists of 28 exons and
encodes the integrin α6 which is a member of integrin
alpha chain family. On the other hand, ITGB4 is located
at 17q25.1 and encodes integrin β4 which is a compo-
nent α6β4 integrin with integrin α6. Most of the patients
with JEB-PA bear pathogenic variants in ITGB4 gene,
while ITGA6 mutations are less common. Integrins are
heterodimeric transmembrane receptors that play a
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critical role in cell surface adhesion and signaling. The
α6β4 integrin is a hemidesmosomal protein, and its ex-
pression is altered by the mutations in ITGA6 and
ITGB4 genes that cause structural defects in hemides-
mosome [10–12].
Here, we describe a clinical case of a newborn with
JEB-PA and ACC due to a novel mutation in ITGB4
gene.
Case presentation
A male preterm infant was born at 31 weeks’ gestation
by vaginal delivery as the first child to consanguineous
parents with a birth weight of 1620 g. On prenatal
ultrasonography, gastric dilatation and unilateral hydro-
nephrosis were described. He received positive pressure
ventilation at the delivery room and transferred to neo-
natal intensive care unit after stabilization. On physical
examination, the skin was absent on the face, anterior
side of the left forearm, both legs, and scrotum. He had
multiple bullous lesions on the right arm, along with
dystrophic nails. The radiograph of the abdomen showed
gastric bubble resembling that of pyloric stenosis (Figs. 1,
2, and 3). Bilateral hydronephrosis and left ureterocele
were detected by abdominal ultrasonography. Echocardi-
ography and cranial ultrasonography were normal. The
patient was intubated due to respiratory failure at the
2nd day of his life. Skin biopsy was performed and
confirmed the diagnosis of EB. During follow-up, intra-
venous hydration was increased and parenteral nutrition
and intravenous albumin were administered. He could
not achieve the required stability for surgery and died on
the 4th day on his life.
Written informed consent was obtained from the par-
ent of the patient.
Fig. 1 Aplasia cutis from the left arm, legs, and scrotum of
the patient
Fig. 2 Dystrophic nails of the patient
Fig. 3 Radiograph of the abdomen showing gastric dilatation due
to pyloric atresia
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Genetic studies
Genomic DNA was isolated from 200 μL of peripheral
blood sample of the patient and his parents using Magna
Pure LC DNA Isolation Kit-Large Volume and Magna
Pure LC instrument (Roche Applied Science, Mannheim,
Germany). All exons and the flanking regions of ITGA6
and ITGB4 were amplified by polymerase chain reaction
using the 100 ng genomic DNA (the 260/280 ratios of
DNA samples were ~ 1.8) as a template for each PCR re-
action. Conditions and primers for generating PCR
products spanning all exons of the coding regions and
flanking intronic sequences of the genes have been pre-
viously described elsewhere [6, 13]. After that, bidirec-
tional Sanger sequencing analysis was performed using
BigDye Terminator v3.1 Cycle Sequencing Kit on an
ABI PRISM 3130 Genetic Analyzer (Thermo Fisher Sci-
entific, Waltham, MA, USA).
A novel homozygous c.565_566+2del mutation was
found in ITGB4 gene of the patient. His parents were
found to be heterozygous for the same mutation (Fig. 4).
This homozygous deletion in ITGB4 disrupts the intron
6 donor splice site and expected to result in aberrant
splicing and loss of function for the encoded β4 integrin
subunit. This variant was not listed in the 1000 Ge-
nomes (http://browser.1000genomes.org) or in the ExAC
database (http://exac.broadinstitute.org).
Discussion
Here, we describe a case with JEB-PA and ACC emer-
ging from a novel splice site mutation in ITGB4 gene.
EB is an inherited disease with an estimated frequency at
1 in 300,000, whereas pyloric atresia (PA) has an inci-
dence of 1 in 100,000 live births. Familial PA with EB
was first described in 1968, and pathophysiology was
first described by Carmi, so the disease has been called
as “Carmi syndrome.” Gastrointestinal, urinary, pulmon-
ary, and eye involvement are also reported to be associ-
ated with EB-PA. ACC has been previously described
with EB-PA in few reports. Literature shows that JEB-
PA-ACC is the most severe spectrum of the disease and
suggested that ACC is the poorest prognostic factor of
the combination [7–9, 11, 14].
Mutations in ITGA6 and ITGB4 cause an altered ex-
pression of α6β4 integrin resulting in a structural defect
of hemidesmosome which has an important role in sta-
bilizing the association of the dermis with the epidermis.
The defective hemidesmosomes cause blisters and
erosions on the skin and gastrointestinal and urogenital
abnormalities [11, 15]. Mutations in ITGA6 are less fre-
quent than in ITGB4 [16]. There are more than 80 mu-
tations that cause EB-PA and some of them are lethal.
In lethal cases, the expression of α6β4 integrin is absent
[17]. We identified a novel, small deletion of the last two
bases in exon 6 and first two nucleotides of intron 6
(c.565_566+2del) in ITGB4 gene in our patient with
Carmi syndrome and ACC. This mutation causes spli-
cing defect and premature stop codon which is respon-
sible for the clinical features of our patient.
Conclusions
EB-PA-ACC is known to be a non-treatable condition
with a poor prognosis. There are few patients reported
to be survived [16]. Although our patient was a prema-
ture baby and intestinal surgery could not be performed,
we thought that the novel mutation reported in this pa-
tient may lead to a lethal form of the disease. Identifica-
tion of underlying genetic abnormality is critical to give
genetic counseling.
Fig. 4 Electropherogram of the index and his parents
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